Paraquat and Parkinson’s Disease: A Systematic Assessment of Recent Epidemiologic Evidence

Main Article Content

Douglas L. Weed

Abstract

A systematic assessment of recent evidence of the possible relationship between exposure to paraquat and Parkinson’s disease was undertaken. A literature search was performed to identify all recently published relevant papers investigating, reviewing, or commenting upon the potential relationship between exposure to paraquat and Parkinson’s Disease. MEDLINE via PubMed and EMBASE library databases were searched from 2019 to 2024 using search terms “paraquat” and “Parkinson.” PRISMA guidelines for reporting systematic reviews were consulted along with the AMSTAR2 evaluation tool used to assess the quality of reviews. A total of 517 publications were identified in the first search and 923 publications in the broader search. After removal of duplicates, 21 publications were determined to be potentially relevant. Identified cohort studies were published between 2019 and 2021 and represented analyses using data from the Agricultural Health Study (AHS) a study designed and funded by the U.S. National Institutes of Health. These studies revealed no association between paraquat exposure and Parkinson’s disease. With the results of the most recent analyses, there is no compelling scientific argument for claiming causality. These studies examined not only general population groups but especially occupationally exposed populations and found no statistically significant increased risk and no evidence of an exposure-response relationship. In the absence of these key causal considerations, the fact that these studies contribute to the inconsistency of the entire epidemiologic database, nonexistent risk increases and dose-response relationships, a lack of experimental evidence, and the absence of a similar—analogous—example in the practice of causal inference, there is no scientific justification for a causal claim. Organizational conclusions are consistent.

Article Details

How to Cite
WEED, Douglas L.. Paraquat and Parkinson’s Disease: A Systematic Assessment of Recent Epidemiologic Evidence. Medical Research Archives, [S.l.], v. 12, n. 9, sep. 2024. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/5767>. Date accessed: 03 oct. 2024. doi: https://doi.org/10.18103/mra.v12i9.5767.
Section
Review Articles

References

1. Parkinson J. An essay on the shaking palsy (1817). J Neuropsychiatry Clin Neurosci. 2002;14:2;223-236.
2. Goetz CG. The history of Parkinson’s Disease: Early clinical descriptions and neurological therapies. Cold Spring Harb Perspect Med. 2011;1:a008862.
3. Ou Z, Pan J, Tang S, et al. Global trends in the incidence, prevalence, and years lived with disability from Parkinson’s disease in 204 countries/territories from 1990 to 2019. Front Public Health. 2021;9:776847.
4. Nabi M, Tabassum N. Role of environmental toxicants on neurodegenerative disorders. Front Toxicol. 2022;4:837579.
5. Ball N, Teo WP, Chandra S, et al. Parkinson’s disease and the environment. Front Neurol. 2019;10:218.
6. Willis AW, Roberts E, Beck JC, et al. Incidence of Parkinson disease in North America. Parkinson’s Disease. 2022;8:170.
7. Belvisi D, Pellicciari R, Fabbrini H, et al. Risk factors of Parkinson’s Disease. Neurology. 2020;95:e2500-2508.
8. Gunnarsson LG, Bodin L. Occupational exposures and neurodegenerative diseases—a systematic literature review and meta-analyses. Int J Environ Res Pub Health. 2019;16:337. doi:10.3390.
9. Weed DL. Does paraquat cause Parkinson’s disease? A review of reviews. Neurotoxicology. 2021;86:180-184.
10. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses. Ann Intern Med. 2009;151:264-269.
11. Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomized or non-randomised studies of healthcare interventions or both. BMJ. 2017;358:j4005/doi:1136/bmjj.4008.
12. McKnight S, Hack N. Toxin-induced Parkinsonism. Neurol Clin. 2020;38:853-865.
13. De Miranda BR, Goldman SM, Miller GW, et al. Preventing Parkinson’s disease: An environmental agenda. J Parkinson’s Dis. 2022;12:45–68.
14. Vellingiri B, Chandrasekhar M, Sabari SS, et al. Neurotoxicity of pesticides – A link to neurodegeneration. Ecotoxicol Environ Saf. 2022;243:113972.
15. Sharma P, Mittal P. Paraquat (herbicide) as a cause of Parkinson’s Disease. Parkinson Relat Disord. 2024;119:105932.
16. Cagac A. Farming, well water consumption, rural living, and pesticide exposure in early life as the risk factors for Parkinson disease in Igdir province. Neurosci. 2020;25:129-135.
17. Perrin L, Spinosi J, Chaperon L, et al. Pesticide expenditures by farming type and incidence of Parkinson disease in farmers: a French nationwide study. Environ Res. 2021;197:111161.
18. Hugh-Jones ME, Peele RH, Wilson VL. Parkinson’s disease in Louisiana, 1999-2012: Based on hospital primary discharge diagnoses, incidence, and risk in relation to local agricultural crops, pesticides, and aquifer recharge. Int J Environ Res Pub Health. 2020;17:1584.
19. Paul KC, Cockburn M, Gong Y, et al. Agricultural paraquat dichloride use and Parkinson’s disease in California’s Central Valley. Int J Epidemiol. 2024;53(1):dyae004.
20. Gamache PL, Salem IH, Roux-Dubois N, et al. Exposure to pesticides and welding hastens the age-at-onset of Parkinson’s disease. Can J Neurol Sci. 2019;46:711-716.
21. Andrew AS, Anderson FL, Lee SL, et al. Lifestyle factors and Parkinson’s disease risk in a rural New England case-control study. Parkinson’s Dis. 2021;5541760.
22. Dardiotis E, Aloizou AM, Sakalakis E, et al. Organochlorine pesticide levels in Greek patients with Parkinson’s disease. Toxicol Rep. 2020;7:596-601.
23. Schneider Medeiros M, Reddy SP, Socal MP, et al. Occupational pesticide exposure and the risk of death in Parkinson’s disease: an observational study in southern Brazil. Environ Health. 2020;19:68.
24. Tomenson JA, Campbell C. Mortality from Parkinson’s disease and other causes among a workforce manufacturing paraquat: An updated retrospective cohort study. J Occup Med Toxicol. 2021;16:20.
25. Shrestha S, Parks CG, Keil AP, et al. Overall and cause-specific mortality in a cohort of farmers and their spouses. Occup Environ Med. 2019;76:632-643.
26. Shrestha S, Parks CG, Umbach DM, et al. Pesticide use and incident Parkinson’s disease in a cohort of farmers and their spouses. Environ Res. 2020;191:110186.
27. Paraquat Dichloride: Systematic Review of the Literature to Evaluate the Relationship Between Paraquat Dichloride Exposure and Parkinson’s Disease. United States Environmental Protection Agency (USEPA). Office of Chemical Safety and Pollution Prevention. June 26, 2019.
28. McLaren L, Hawe P. Ecological perspectives in health research. J Epidemiol Commun Health. 2005;59:6-14.
29. Holland PW. Statistics and causal inference. J Am Stat Assoc. 1986;81:945-960.
30. United States Preventive Services Task Force (USPSTF). Procedure Manual. December, 2015.
31. Alavanja MCR, Sandler DP, McMaster SB, et al. The Agricultural Health Study. Environ Health Perspect. 1996;104:362-369.
32. Hill AB. The environment and disease: association or causation? Proc Roy Soc Med. 1965;58:295-300.
33. Weed DL. 2018. Analogy in causal inference: rethinking Austin Bradford Hill’s neglected consideration. Ann Epidemiol. 28:343-346.
34. Boden LI, Ozonoff D. Litigation-generated science: Why should we care? Environ Health Perspect. 2008;116:117-122.
35. Pearce N. Corporate influences on epidemiology. Int J Epidemiol. 2008;37:46-53.
36. Haas J. Commentary: Epidemiology and the pharmaceutical industry: an inside perspective. Int J Epidemiol. 2008;37:53-55.
37. Acquavella JF. The politics of identity in epidemiology. Ann Epidemiol. 1997;7:431-437.